Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.485 SEK | +5.66% | +6.48% | -7.27% |
04-16 | Mendus AB Announces Board Changes | CI |
03-27 | Mendus AB Announces Ethics Committee Approval for the AMLM22-CADENCE Trial with Lead Product Vididencel in AML | CI |
- Stock Market
- Equities
- IMMU Stock
- News Mendus AB
- Highlights